A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcome

medRxiv - The Preprint Server for Health Sciences

Frontiers Association of Clinical and Immunological Characteristics With Disease Severity and Outcomes in 211 Patients With COVID-19 in Wuhan, China

Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples - eBioMedicine

Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function, Journal of Translational Medicine

Mathematics, Free Full-Text

Frontiers Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors

Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients

COVID-19_arXiv on X: 𝗧𝗶𝘁𝗹𝗲: A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcome. 𝗔𝘂𝘁𝗵𝗼𝗿𝘀: Vadim Demichev, Pinkus Tober-Lau, Tatiana Nazarenko, Charlotte Thibeault, Harry Whitwell

Frontiers Towards Building a Quantitative Proteomics Toolbox in Precision Medicine: A Mini-Review

Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity - ScienceDirect

Immunohematologic Biomarkers in COVID-19: Insights into Pathogenesis, Prognosis, and Prevention

Frontiers Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods

Plasma proteome dynamics of COVID-19 severity learnt by a graph convolutional network of multi-scale topology

A time-resolved proteomic and prognostic map of COVID-19 - ScienceDirect

AI-powered therapeutic target discovery: Trends in Pharmacological Sciences

A Multi-omics Longitudinal Study Reveals Alteration of the Leukocyte Activation Pathway in COVID-19 Patients